CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
4 hedge funds and large institutions have $631K invested in Loncar China BioPharma ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$464K |
2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$44K |
3 |
MCM
MV Capital Management
Bethesda,
Maryland
|
+$19K |
Top Sellers
1 |
Jane Street
New York
|
-$773K |
2 |
UBS Group
Zurich,
Switzerland
|
-$62K |
3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |